Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

This study has been completed.

Study NCT00061477 Information provided by Eli Lilly and Company

First Received: May 28, 2003 Last Updated: January 24, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2006
Estimated Primary Completion Date:	No date given